Ocular Therapeutix to Resume Trading at 9:15 AM ET
Ocular Therapeutix, which announced plans to showcase its FDA-aligned plans to submit its NDA for AXPAXLI, is set to resume trading at 9:15am ET, with quotation scheduled to resume at 9:10am ET, according to Nasdaq.
